|
|||||
|
|
Nivolumab versus irinotecan as third- or later-line treatment for advanced gastric cancer: a multi-center retrospective study |
|
| Authors: | Kumanishi Ryosuke Kadowaki Shigenori Mitani Seiichiro Matsushima Tomohiro Ogata Takatsugu Narita Yukiya Masuishi Toshiki Bando Hideaki Tajika Masahiro Yasui Hisateru Hara Hiroki Muro Kei |
| Affiliation: | 1.Department of Clinical Oncology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa-Ku, Nagoya, Aichi, 464-8681, Japan ;2.Department of Gastroenterology, Saitama Cancer Center, Saitama, Japan ;3.Department of Medical Oncology, Kobe City Medical Center General Hospital, Kobe, Japan ;4.Department of Medical Oncology, Faculty of Medicine, Kindai University, Osaka-Sayama, Japan ;5.Department of Endoscopy, Aichi Cancer Center Hospital, Nagoya, Japan ; |
| Abstract: | International Journal of Clinical Oncology - The present study aimed to compare the efficacy and safety of nivolumab (NIVO) and irinotecan (IRI) and to identify clinical factors that facilitate... |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ | |